Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 208
8
Diseases
11
Unique genes
0.289
Avg. similarity score
Craniometadiaphyseal dysplasia
Most-connected disease (7 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Craniometadiaphyseal dysplasia
Craniometaphyseal dysplasia
Chondrocalcinosis
Autoinflammation, panniculitis, and dermatosis syndrome
Calcium metabolism disorders
autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive
Calcium pyrophosphate deposition
Schwartz-lelek syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Craniometadiaphyseal dysplasia | 7 | 7 | 2 |
| Craniometaphyseal dysplasia | 7 | 7 | 3 |
| Chondrocalcinosis | 6 | 6 | 3 |
| Autoinflammation, panniculitis, and dermatosis syndrome | 5 | 5 | 1 |
| Calcium metabolism disorders | 5 | 5 | 8 |
| autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive | 5 | 5 | 1 |
| Calcium pyrophosphate deposition | 4 | 4 | 2 |
| Schwartz-lelek syndrome | 3 | 3 | 2 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ANKH | 6 / 8 | Calcium metabolism disorders, Calcium pyrophosphate deposition, Chondrocalcinosis, Craniometadiaphyseal dysplasia and 2 more |
| OTULIN | 6 / 8 | Autoinflammation, panniculitis, and dermatosis syndrome, autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive, Calcium metabolism disorders, Chondrocalcinosis and 2 more |
| GJA1 | 2 / 8 | Craniometaphyseal dysplasia, Schwartz-lelek syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cortisol synthesis and secretion | KEGG | 2 / 65 | 33.6× | 1.54e-3 | 1.88e-2 ✓ sig. |
| Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD) | Reactome | 1 / 2 | 546× | 1.83e-3 | 2.14e-2 ✓ sig. |
| Peptide hormone biosynthesis | Reactome | 1 / 2 | 546× | 1.83e-3 | 2.14e-2 ✓ sig. |
| Regulation of gap junction activity | Reactome | 1 / 3 | 364× | 2.75e-3 | 2.89e-2 ✓ sig. |
| Opioid Signalling | Reactome | 1 / 3 | 364× | 2.75e-3 | 2.89e-2 ✓ sig. |
| Gap junction | KEGG | 2 / 89 | 24.5× | 2.86e-3 | 2.97e-2 ✓ sig. |
| Aldosterone synthesis and secretion | KEGG | 2 / 98 | 22.3× | 3.46e-3 | 3.40e-2 ✓ sig. |
| Parathyroid hormone synthesis, secretion and action | KEGG | 2 / 115 | 19.0× | 4.72e-3 | 4.22e-2 ✓ sig. |
| Nef Mediated CD8 Down-regulation | Reactome | 1 / 7 | 156× | 6.40e-3 | 5.15e-2 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | Reactome | 1 / 8 | 136× | 7.31e-3 | 5.62e-2 |
| Nef Mediated CD4 Down-regulation | Reactome | 1 / 9 | 121× | 8.22e-3 | 6.07e-2 |
| Acetylcholine regulates insulin secretion | Reactome | 1 / 9 | 121× | 8.22e-3 | 6.07e-2 |
| Cushing syndrome | KEGG | 2 / 155 | 14.1× | 8.43e-3 | 6.18e-2 |
| Glucocorticoid biosynthesis | Reactome | 1 / 10 | 109× | 9.12e-3 | 6.50e-2 |
| Retrograde neurotrophin signalling | Reactome | 1 / 11 | 99.3× | 1.00e-2 | 6.86e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| skeletal system development | GO:0001501 | 3 / 151 | 33.8× | 8.14e-5 | 2.59e-3 ✓ sig. |
| positive regulation of insulin secretion | GO:0032024 | 2 / 60 | 56.6× | 5.47e-4 | 1.01e-2 ✓ sig. |
| microtubule-based transport | GO:0099111 | 1 / 1 | 1,699× | 5.89e-4 | 1.07e-2 ✓ sig. |
| regulation of melanocyte differentiation | GO:0045634 | 1 / 1 | 1,699× | 5.89e-4 | 1.07e-2 ✓ sig. |
| cellular pigmentation | GO:0033059 | 1 / 1 | 1,699× | 5.89e-4 | 1.07e-2 ✓ sig. |
| positive regulation of oxytocin production | GO:0140668 | 1 / 1 | 1,699× | 5.89e-4 | 1.07e-2 ✓ sig. |
| regulation of blood pressure | GO:0008217 | 2 / 83 | 40.9× | 1.04e-3 | 1.55e-2 ✓ sig. |
| spontaneous synaptic transmission | GO:0098814 | 1 / 2 | 849× | 1.18e-3 | 1.66e-2 ✓ sig. |
| positive regulation of neutrophil mediated killing of fungus | GO:0070965 | 1 / 2 | 849× | 1.18e-3 | 1.66e-2 ✓ sig. |
| regulation of corticosterone secretion | GO:2000852 | 1 / 2 | 849× | 1.18e-3 | 1.66e-2 ✓ sig. |
| negative regulation of gonadotropin secretion | GO:0032277 | 1 / 2 | 849× | 1.18e-3 | 1.66e-2 ✓ sig. |
| positive regulation of morphogenesis of an epithelium | GO:1905332 | 1 / 2 | 849× | 1.18e-3 | 1.66e-2 ✓ sig. |
| negative regulation of odontogenesis of dentin-containing tooth | GO:0042489 | 1 / 2 | 849× | 1.18e-3 | 1.66e-2 ✓ sig. |
| polysaccharide metabolic process | GO:0005976 | 1 / 3 | 566× | 1.76e-3 | 2.11e-2 ✓ sig. |
| response to melanocyte-stimulating hormone | GO:1990680 | 1 / 3 | 566× | 1.76e-3 | 2.11e-2 ✓ sig. |